A positive correlation between the polymorphism of PAD4 gene and the incidence of RA has been revealed (39, 40), which is better explained by the fact that the PAD4 inhibitor chloropyrimidine can alleviate the symptoms of collagen-induced arthritis (CIA) in mice and rats (41). This evidence concerns the gene PADI4 and rheumatoid arthritis.